| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |